BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 539014)

  • 1. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New results concerning the effectiveness of therapy of chronic glomerulonephritis. Results of cytostatics-anticoagulants-aggregation inhibitors, cystostatics-anticoagulants-aggregation inhibitors-prednisone and cystostatics-prednisone therapy, derived from a retrospective study].
    Sinn W; Ratner M; Tomilina N; Klinkmann H; Nizze H
    Z Urol Nephrol; 1986 Aug; 79(8):449-57. PubMed ID: 3535293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A clinico-morphological analysis of the efficacy of therapy in chronic glomerulonephritis using prednisone, a cytostatic, an anticoagulant and an antiaggregant].
    Ratner MIa; Fedorova ND
    Urol Nefrol (Mosk); 1996; (2):32-5. PubMed ID: 8677550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa; Tomilina NA; Biriukova LS; Monchakovskiĭ SF
    Ter Arkh; 1985; 57(6):69-74. PubMed ID: 4071418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined immunosuppressive and anticoagulant treatment in children with glomerulonephritis and declining renal function.
    Savage JM; Postlethwaite RJ; Lendon M; Houston IB; Evans DI
    Int J Pediatr Nephrol; 1982 Sep; 3(3):167-73. PubMed ID: 7141788
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Kozlov VV; Kucher AG
    Ter Arkh; 1994; 66(8):52-7. PubMed ID: 7985156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa; Serov VV; Varshavskiĭ VA; Biriukova LS; Stenina II
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Special pharmacotherapy of primary glomerulonephritis in the adult].
    Thiele KG
    Dtsch Med Wochenschr; 1975 Sep; 100(36):1803-4. PubMed ID: 1157682
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prolonged treatment of mesangioproliferative glomerulonephritis with a cytostatic agent and prednisolone and a combination of a cytostatic agent, prednisolone an anticoagulant and an antiaggregant].
    Ratner MIa; Tomilina NA; Klinkman Kh; Shmitt E; Kreger E
    Ter Arkh; 1980; 52(8):106-10. PubMed ID: 7256574
    [No Abstract]   [Full Text] [Related]  

  • 12. [A comparative evaluation of the efficacy of treatment methods in chronic glomerulonephritis].
    Riabov SI; Stavskaia VV; Sheveleva LA
    Ter Arkh; 1990; 62(9):91-7. PubMed ID: 2281418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation.
    Chapman SJ; Cameron JS; Chantler C; Turner D
    Arch Dis Child; 1980 Jun; 55(6):446-51. PubMed ID: 7436483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current trends in the treatment of primary glomerulonephritis].
    Ponticelli C; Passerini P
    Minerva Urol Nefrol; 1984; 36(4 Suppl):7-13. PubMed ID: 6398922
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful pregnancy outcome with combination therapy in women with the antiphospholipid antibody syndrome.
    Menashe Y; Ben-Baruch G; Greenspoon JS; Carp HJ; Rosen DJ; Mashiach S; Many A
    J Reprod Med; 1993 Aug; 38(8):625-9. PubMed ID: 8410869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of treatment of glomerulonephritis with anticoagulants, antiaggregants, cytostatics and methindol].
    Riabov SI; Minkin RB; Rabukhina VA; Tarasova NA; Polenova IM
    Ter Arkh; 1978; 50(9):114-8. PubMed ID: 705640
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dosage heparin in rapidly progressive glomerulonephritis.
    Fye KH; Hancock D; Moutsopoulos H; Humes HD; Arieff AI
    Arch Intern Med; 1976 Sep; 136(9):995-9. PubMed ID: 962457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are anticoagulants beneficial in the treatment of rapidly progressive glomerulonephritis?
    Cameron JS
    Proc Eur Dial Transplant Assoc; 1973; 10(0):57-90. PubMed ID: 4606240
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapidly progressive glomerulonephritis treated with anticoagulants.
    Arieff AI; Pinggera WF
    Arch Intern Med; 1972 Jan; 129(1):77-84. PubMed ID: 4550298
    [No Abstract]   [Full Text] [Related]  

  • 20. [A clinico-pathogenetic approach to choosing the therapeutic procedure in chronic glomerulonephritis].
    Tov NL; Sidorova LD; Valentik MF; Movchan EA; Savitskaia IV; Nekipelova VI; Dorofeev SB; Nesina IA
    Ter Arkh; 1990; 62(6):37-42. PubMed ID: 2218924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.